Sialic acid (SA)-modified selenium nanoparticles coated with a high blood–brain barrier permeability peptide-B6 peptide for potential use in Alzheimer’s diseaseTiantian Yin, Jie Liu, Jing Sun et al.|Acta Biomaterialia|2015Cited by 193
Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer’s disease treatmentLicong Yang, Jie Liu, Tiantian Yin et al.|Acta Biomaterialia|2016Cited by 116